 |
The BU CTSI is launching a voucher program to support the short-term needs of investigators whose time to conduct research has been negatively impacted by pandemic-related family care or other home responsibilities. Read Full Details
|
Applications to be accepted on a rolling basis until December 31, 2020 |
|
|
|
> Electronic Health Records
(EHR) Common Capabilities 1
> Leadership, Management, and Planning 1
> EHR Common Capabilities 2
> Leadership, Management, and Planning 2
|
|
BU CTSI has partnered with Indiana CTSI and Regenstrief Institute to offer four continuing education classes starting October 5. Each class is intended to offer practical, ready-to-use value where health IT and research overlap. |
|
New Funding Opportunities |
|
|
Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
National Institute of Allergy and Infectious Diseases (NIAID)
|
|
|
|
Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
|
|
|
|
|
NIMHD is participating in 4 Funding Opportunity Announcements for the RADx Underserved Populations initiative to reduce COVID19–associated morbidity and mortality disparities for vulnerable and underserved populations.
|
|
|
|
|
Due: Mid-November
Funding: $230,000
Project Period: 3 years
Purpose: To support collaborative research by US and Israeli research teams in the areas of biomedical engineering, life sciences, medicine, psychobiology, exact physical sciences, and social sciences. Proposals related to COVID-19 in these priority areas are welcome.
|
|
|
|
Due: September 3, 2020
Funding: $50,000
Project Period: 1 year
Purpose: To address the challenges primary care providers experience in serving adults with intellectual and developmental disabilities during pandemic and/or emergency situations.
|
|
|
|
|
|
Racial Disproportionality in Covid Clinical Trials |
Despite disproportionately higher rates of Covid-19 infection, hospitalization, and death in racial and ethnic minority groups, the direct effects of genetic or biologic host factors remain unknown.
|
|
Cellular Signaling Proteins as Potential Targets for Novel Antidiabetic Drugs |
NIH researchers shed new light on the mechanisms of diabetes and have identified possible new targets for treatment.
|
|
|
|
|
A Long Tradition of Vaccine Breakthroughs |
The NIH has been making contributions to vaccine development for more than 100 years, developing technology and expertise that were vital to the development of the coronavirus vaccine now undergoing a phase 3 clinical trial.
|
|
Looking for resources to help you apply & advance your biomedical project? Check out NIH RePORTER,
a research tool to use to see what areas of interest have been funded by NCATS.
|
|
|
|
Neutralizing Antibodies Scientific Summit –
August 20, 2020, 12:30–4:00 p.m. ET
|
Operation Warp Speed, in collaboration with the NIH, is hosting a virtual scientific summit to explore the current state and future opportunities for neutralizing antibodies (nAbs) as a possible treatment for COVID-19.
|
|
|
|
|
Virtual Seminar: Engaging Patients in the Research Process –
August 26, 2020, 1:00–3:30 p.m. ET
|
The NIH HEAL Initiative will host the virtual seminar Engaging Patients in the Research Process, to increase the understanding of how to incorporate patients’ perspectives and insights at all levels and phases of clinical studies, from conception and design through recruitment, and dissemination of findings
|
|
|
|
|
Pre-Application Webinar: Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44) – August 27, 2020, 2:00 p.m. ET
|
This webinar will provide prospective applicants with an overview of the SBIR U44 funding announcement and discuss NIA's critical focus areas and research priorities designed for the U44. The NIA and ACL staff will moderate a Q&A discussion to answer questions regarding the scope of this funding opportunity announcement and technical details regarding your application.
|
|
|
|
|
Third Annual Children's National – NIAID Virtual Symposium –
September 29, 2020, 9:00 a.m. & 4:00 p.m. ET
|
This year's event will highlight the current COVID-19 and MIS-C pandemic, with a specific focus on the pediatric population. Dr. Anthony Fauci, Director of NIAID, will provide an overview on the infectious disease, and leading experts from Children’s National, NIAID, and other institutions will share the novel research and science being done to address this worldwide issue.
|
|
|
|
|
AMIA 2020 Virtual Annual Symposium – November 14 -18, 2020
|
The AMIA 2020 Annual Symposium showcases the latest innovations from the community of biomedical informatics researchers and practitioners. Topics of interest span the spectrum from deciphering the underpinning phenomena of disease, to managing information and communications for improving patient care, to tracking the health of populations.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
